对Myocilin基因Gln368Stop突变的评估显示欧洲人群中青光眼外显率降低
该横断面队列研究利用TwinsUK(N=6092)和鹿特丹研究(N=11189)两个欧洲人群队列,评估MYOC基因rs74315329(Gln368Stop)突变携带者中眼压升高或青光眼的外显率。结果显示TwinsUK和鹿特丹研究中该突变与眼压升高的外显率分别为12.5%和19.4%,远低于既往报道。作者认为该突变外显率较低,识别携带者作为青光眼筛查工具的效用有限。
要点
- TwinsUK队列中rs74315329突变与眼压升高的观察外显率为12.5%。
- 鹿特丹研究队列中rs74315329突变与眼压升高的观察外显率为19.4%。
- 该突变外显率远低于既往报道,识别携带者作为青光眼筛查工具的效用降低。
核心结论
- 本研究发现rs74315329突变导致眼压升高(进而导致青光眼)的外显率远低于既往报道,识别该突变携带者作为青光眼筛查工具的效用因此降低。
研究设计与样本
- 横断面队列研究,在TwinsUK(N=6092)和鹿特丹研究(N=11189)两个基于人群的队列中评估rs74315329变异的外显率。
- 通过全基因组测序和基于1000 Genomes Project与Haplotype Reference Consortium面板的填充数据识别风险等位基因携带者。
- 利用眼压测量和视野检查/青光眼诊断数据(如有)评估该变异的外显率。
主要发现
- TwinsUK队列中rs74315329突变与眼压升高相关的观察外显率为12.5%。
- 鹿特丹研究队列中rs74315329突变与眼压升高相关的观察外显率为19.4%。
- 上述外显率远低于既往报道的rs74315329导致眼压升高(进而导致青光眼)的外显率。
关键数值与推荐
- MYOC基因序列变异约占青光眼病例的2%至4%。
- Gln368Stop(dbSNP编号:rs74315329)是导致眼压升高进而引起青光眼的最常见遗传突变。
临床怎么用
- 作者认为,该突变外显率较低意味着人群中更多健康个体为该突变携带者,从而降低了将识别该突变携带者作为青光眼筛查工具的效用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Sequence variations in the myocilin (MYOC) gene account for approximately 2% to 4% of glaucoma cases. One particular MYOC mutation, Gln368Stop (dbSNP accession number: rs74315329), is the most common genetic mutation causing glaucoma by increasing intraocular pressure (IOP). The objective of this study was to evaluate the effect of this MYOC mutation on IOP using data from large-scale European population panels (directly sequenced and imputation based). DESIGN: Cross-sectional, cohort study. PARTICIPANTS: For this study, the penetrance of the variant rs74315329 was estimated in 2 population-based cohorts, the TwinsUK (N = 6092) and the Rotterdam Study (RS) (N =11 189). METHODS: Carriers of the risk allele for rs74315329 were identified using whole-genome sequencing and imputation data (based on 1000 Genomes Project and Haplotype Reference Consortium panels). The penetrance of this variant was evaluated using IOP measurements and data on visual field testing/a diagnosis of glaucoma (if available). MAIN OUTCOME MEASURES: The penetrance of the variant rs74315329 was estimated from the percentage of the carriers of the risk allele of the variant who had high IOP (ocular hypertension) or glaucoma. RESULTS: In our study, the observed penetrance of the variant rs74315329 in relation to increased IOP was 12.5% and 19.4% in the TwinsUK and the RS, respectively. Thus, our study suggests a much lower penetrance for rs74315329 for ocular hypertension (and thus glaucoma), in comparison with that reported previously. CONCLUSIONS: The significance of this finding is that higher numbers of healthy individuals in the population are expected to be carriers of this mutation, which in turn reduces the utility of identifying carriers of this mutation as a screening tool for glaucoma.
引用
- Nag A, Lu H, Arno M, et al. Evaluation of the Myocilin Mutation Gln368Stop Demonstrates Reduced Penetrance for Glaucoma in European Populations. Ophthalmology. 2016. PMID: 28038983. doi:10.1016/j.ophtha.2016.11.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。